Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haider Mahdi

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancerAnca Chelariu-Raicu, Haider Mahdi, Brian M Slomovitz
Obstetrics and Gynecology|July 20, 2011
Pagetoid adenocarcinoma in situ of the cervix with pagetoid spread into the vaginaHaider Mahdi, Melissa Thrall, Nicholas Agoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 1, 2017
Trends in Survival of Patients With Uterine Serous Carcinoma From 1988 to 2011: A Population-Based StudyHaider Mahdi, Xiaozhen Han, Laura Moulton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Immunotherapy in endometrial cancerHaider Mahdi, Anca Chelariu-Raicu, Brian M Slomovitz
Obstetrics and Gynecology|July 26, 2013
Peripartum robotic-assisted laparoscopic hysterectomy after second-trimester pregnancy loss with placenta incretaStephanie Boes, Haider Mahdi, Fadi Khoury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 16, 2015
Impact of Age on 30-Day Mortality and Morbidity in Patients Undergoing Surgery for Ovarian CancerHaider Mahdi, Andrew Wiechert, David Lockhart, et al.
Journal of Gynecologic Oncology|May 26, 2017
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactionsKathryn Maurer, Chad Michener, Haider Mahdi, et al.
Obstetrics and Gynecology|November 23, 2013
In replyStephanie Boes, Haider Mahdi, Fadi Khoury, et al.
Journal of Surgical Oncology|August 8, 2015
Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinomaHaider Mahdi, Joanne Xiu, Sandeep K Reddy, et al.
Gynecologic Oncology|March 8, 2016
Racial disparity in survival of patients with uterine serous carcinoma: Changes in clinical characteristics, patterns of care and outcomes over time from 1988 to 2011Haider Mahdi, Xiaozhen Han, Fadi Abdul-Karim, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancerAnca Chelariu-Raicu, Haider Mahdi, Brian M Slomovitz
Obstetrics and Gynecology|July 20, 2011
Pagetoid adenocarcinoma in situ of the cervix with pagetoid spread into the vaginaHaider Mahdi, Melissa Thrall, Nicholas Agoff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 1, 2017
Trends in Survival of Patients With Uterine Serous Carcinoma From 1988 to 2011: A Population-Based StudyHaider Mahdi, Xiaozhen Han, Laura Moulton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Immunotherapy in endometrial cancerHaider Mahdi, Anca Chelariu-Raicu, Brian M Slomovitz
Obstetrics and Gynecology|July 26, 2013
Peripartum robotic-assisted laparoscopic hysterectomy after second-trimester pregnancy loss with placenta incretaStephanie Boes, Haider Mahdi, Fadi Khoury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 16, 2015
Impact of Age on 30-Day Mortality and Morbidity in Patients Undergoing Surgery for Ovarian CancerHaider Mahdi, Andrew Wiechert, David Lockhart, et al.
Journal of Gynecologic Oncology|May 26, 2017
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactionsKathryn Maurer, Chad Michener, Haider Mahdi, et al.
Obstetrics and Gynecology|November 23, 2013
In replyStephanie Boes, Haider Mahdi, Fadi Khoury, et al.
Journal of Surgical Oncology|August 8, 2015
Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinomaHaider Mahdi, Joanne Xiu, Sandeep K Reddy, et al.
Gynecologic Oncology|March 8, 2016
Racial disparity in survival of patients with uterine serous carcinoma: Changes in clinical characteristics, patterns of care and outcomes over time from 1988 to 2011Haider Mahdi, Xiaozhen Han, Fadi Abdul-Karim, et al.
Pageof 9